SabrinaMariaWitherbyMD

Oncology • Providence, RI

Breast Cancer

Assistant Professor of Medicine, Brown University Health Cancer Institute

Join to view full profile

Dr. Witherby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Witherby's full profile

Already have an account?

Office
164 Summit Avenue
Miriam Hospital
Providence, RI 02906

Summary

Sabrina Witherby, MD is an oncologist based in Providence, RI, with a subspecialty in breast cancer. A graduate from the University of Massachusetts Medical School in 2001, she completed a residency in Internal Medicine at Brown University (2001-2004) and a fellowship in Hematology and Medical Oncology at the University of Vermont Medical Center (2004-2007). Dr. Witherby is board certified in hematology/oncology but sees primarily breast cancer patients and focuses on medical education.

Education & Training

University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2001 - 2004
University of Massachusetts Medical SchoolClass of 2001

Certifications & Licensure

MA State Medical License 2017 - 2026
RI State Medical License 2007 - 2026
VT State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. Start of enrollment: 2006 Dec 01
Suspended
Phase 1, Phase 2

Publications & Presentations

PubMed

Fulfilling the Role of a Parent While Undergoing Treatment for Cancer: A Review of the Literature and the Potential Impact of Childcare Support on Cancer Outcomes.
Kang Woo Kim, Mary Lopresti, Stephanie L Graff, Sabrina Witherby, Don S Dizon
American Journal of Clinical Oncology. 2024-09-01
2 citations
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.
Mary L Lopresti, Jessica J Bian, Bachir J. Sakr, Rochelle Strenger, Robert D. Legare
Breast Cancer Research and Treatment. 2021-06-04
6 citations
Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic
Chelsey C Ciambella, Charu Taneja, Don S. Dizon, Doreen L Wiggins, Christine M Emmick
Annals of Surgical Oncology. 2019-07-24